Related by context. Frequent words. (Click for all words.) 65 CALGB 65 Pivotal Phase III 64 Phase Ib II 64 Pivotal Trial 63 Eculizumab 63 Phase III Clinical Trial 63 Phase Ib clinical 63 Initiates Phase II 63 Phase III Trial 63 phase IIa clinical 62 multicenter clinical 62 EVEREST II 62 ASH Annual Meeting 62 Patient Enrollment 61 Gastric Cancer 61 Prostate Cancer Prevention 61 Randomized controlled 61 Tesetaxel 61 Acute Myocardial Infarction 61 Surgical Treatment 61 Pivotal Study 60 Clinical Trial Results 60 Hepatocellular Carcinoma 60 Pulmonary Arterial Hypertension 60 Genasense ® 60 Patient Outcomes 60 Gynecologic Oncology Group 60 Patient Registry 59 Pirfenidone 59 phase IIb clinical 59 Metastatic Melanoma 59 Cytori Therapeutics NASDAQ CYTX 59 Daclizumab 59 prospective multicenter 59 Initiate Phase 59 multicenter prospective 59 Completes Enrollment 59 metastatic castration resistant 59 Microplasmin 59 ACRIN 59 Pivotal Phase 59 Phase IIIb 59 Receives Orphan Drug Designation 58 Metastatic Colorectal Cancer 58 phase IIa 58 II Clinical Trial 58 StemEx 58 Talactoferrin 58 multicenter Phase 58 NeuroStar TMS Therapy 58 Multicenter 58 Belatacept 58 ThermoDox R 58 Amorcyte 58 ABSORB trial 58 Chronic Lymphocytic Leukemia 58 Power3 Medical 58 metastatic hormone refractory 58 ONTARGET 58 randomized Phase III 57 SPIRIT IV 57 Heart Failure Patients 57 Commences Phase 57 RE LY 57 Anticoagulation 57 Inclinix 57 SABCS 57 ongoing Phase 1b 57 Diagnostic Ultrasound 57 Apixaban 57 relapsing multiple sclerosis 57 KRN# 57 Acute Ischemic Stroke 57 Single Dose 57 Chronic Heart Failure 57 GEM OS1 57 phase Ib 57 Allograft 57 forodesine 57 Diabetic Macular Edema 57 Regado Biosciences 57 TACI Ig 57 GSK# [001] 57 Cethromycin 56 Phase 1b clinical 56 Phase Ia 56 Cancer Immunotherapy 56 AVADO 56 placebo controlled clinical 56 Cardiovascular Imaging 56 Preclinical Data 56 Gastrointestinal Cancer 56 Carotid 56 Cervical Cancer Screening 56 NSABP 56 Clinical Oncology Annual Meeting 56 Gastrointestinal Cancers Symposium 56 Epratuzumab 56 Announces FDA Clearance 56 TARGIT 56 Lovaxin C